Effects of CaMKIV on DC activation markers
| . | Mock . | WT . | DN . |
|---|---|---|---|
| Regular medium | |||
| CD86 (MFI) | 350 ± 125 | 950 ± 320* | 270 ± 160 |
| CD83, % | 10 ± 5 | 8± 2 | 7 ± 3 |
| A-V, % | 55 ± 14 | 28± 17* | 63 ± 22 |
| Viability, % | 35 ± 12 | 67± 16* | 32 ± 18 |
| LPS | |||
| CD86 (MFI) | 1140 ± 250 | 1250 ± 305 | 1070 ± 360 |
| CD83, % | 52 ± 13 | 48± 20 | 51 ± 18 |
| A-V, % | 28 ± 10 | 23± 15 | 65 ± 19* |
| Viability, % | 65 ± 11 | 62± 15 | 30 ± 16* |
| . | Mock . | WT . | DN . |
|---|---|---|---|
| Regular medium | |||
| CD86 (MFI) | 350 ± 125 | 950 ± 320* | 270 ± 160 |
| CD83, % | 10 ± 5 | 8± 2 | 7 ± 3 |
| A-V, % | 55 ± 14 | 28± 17* | 63 ± 22 |
| Viability, % | 35 ± 12 | 67± 16* | 32 ± 18 |
| LPS | |||
| CD86 (MFI) | 1140 ± 250 | 1250 ± 305 | 1070 ± 360 |
| CD83, % | 52 ± 13 | 48± 20 | 51 ± 18 |
| A-V, % | 28 ± 10 | 23± 15 | 65 ± 19* |
| Viability, % | 65 ± 11 | 62± 15 | 30 ± 16* |
Means are plus or minus SD. MFI indicates mean fluorescence intensity; and A-V, annexin-V.
indicates statistical significance (n = 3); P < .01.